ArticleNeurology. Clinical practice2021

Treatment of Dementia With Bosutinib: An Open-Label Study of a Tyrosine Kinase Inhibitor.

Kennedy D Mahdavi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.